GlassScriptPhysician profile
Timothy J Roth
NPI 1194795336
$5,683.69
in general payments reported to CMS, 2019-2025
41 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,022 · 2020: $479 · 2021: $1,106 · 2022: $751 · 2023: $338 · 2024: $847 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716 · Travel and Lodging: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,716.44 |
| Travel and Lodging | $608.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,116.71 | 2019-2025 | Solyx Sis System, Axonics, Lithovue |
| Axonics, INC. | $702.70 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $489.47 | 2019-2022 | |
| Teleflex LLC | $328.64 | 2021-2024 | Urolift |
| Myovant Sciences INC. | $317.26 | 2021-2022 | |
| Angiodynamics, INC. | $218.92 | 2025 | Nanoknife |
| Coloplast Corp | $177.75 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $164.49 | 2019-2022 | |
| Allergan, INC. | $164.07 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $157.44 | 2021-2024 | Lynparza |
| Bluewind Medical | $146.28 | 2024 | Revi |
| Antares Pharma, INC. | $142.16 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $133.30 | 2021-2024 | Keytruda |
| Laborie Medical Technologies Corp. | $130.50 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Neotract INC. | $124.49 | 2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.